Annual ROE
-278.72%
-198.21%-246.19%
December 31, 2023
Summary
- As of February 8, 2025, VIRX annual return on equity is -278.72%, with the most recent change of -198.21% (-246.19%) on December 31, 2023.
- During the last 3 years, VIRX annual ROE has fallen by -319.88% (-777.16%).
- VIRX annual ROE is now -777.16% below its all-time high of 41.16%, reached on December 31, 2020.
Performance
VIRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-680.30%
-388.18%-132.88%
September 30, 2024
Summary
- As of February 8, 2025, VIRX quarterly return on equity is -680.30%, with the most recent change of -388.18% (-132.88%) on September 30, 2024.
- Over the past year, VIRX quarterly ROE has dropped by -534.65% (-367.08%).
- VIRX quarterly ROE is now -1752.82% below its all-time high of 41.16%, reached on December 31, 2020.
Performance
VIRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VIRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -246.2% | -367.1% |
| 3 y3 years | -777.2% | -367.1% |
| 5 y5 years | -777.2% | -367.1% |
VIRX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -246.2% | at low | -1380.2% | at low |
| 5 y | 5-year | -777.2% | at low | -1752.8% | at low |
| alltime | all time | -777.2% | at low | -1752.8% | at low |
Viracta Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -680.30%(+132.9%) |
| Jun 2024 | - | -292.12%(+52.5%) |
| Mar 2024 | - | -191.60%(+31.5%) |
| Dec 2023 | -278.72%(+246.2%) | -145.65%(+39.9%) |
| Sep 2023 | - | -104.08%(+8.9%) |
| Jun 2023 | - | -95.58%(+20.8%) |
| Mar 2023 | - | -79.15%(+17.3%) |
| Dec 2022 | -80.51% | -67.50%(+8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -61.97%(+17.7%) |
| Jun 2022 | - | -52.63%(+14.5%) |
| Mar 2022 | - | -45.96%(-55.9%) |
| Dec 2021 | -121.61%(-395.5%) | -104.28%(-28.7%) |
| Sep 2021 | - | -146.32%(-3.4%) |
| Jun 2021 | - | -151.45%(-36.6%) |
| Mar 2021 | - | -238.93%(-680.5%) |
| Dec 2020 | 41.16% | 41.16% |
FAQ
- What is Viracta Therapeutics annual return on equity?
- What is the all time high annual ROE for Viracta Therapeutics?
- What is Viracta Therapeutics annual ROE year-on-year change?
- What is Viracta Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly ROE year-on-year change?
What is Viracta Therapeutics annual return on equity?
The current annual ROE of VIRX is -278.72%
What is the all time high annual ROE for Viracta Therapeutics?
Viracta Therapeutics all-time high annual return on equity is 41.16%
What is Viracta Therapeutics annual ROE year-on-year change?
Over the past year, VIRX annual return on equity has changed by -198.21% (-246.19%)
What is Viracta Therapeutics quarterly return on equity?
The current quarterly ROE of VIRX is -680.30%
What is the all time high quarterly ROE for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly return on equity is 41.16%
What is Viracta Therapeutics quarterly ROE year-on-year change?
Over the past year, VIRX quarterly return on equity has changed by -534.65% (-367.08%)